Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2

Nicholas E. Ingraham; David Boulware; Matthew A. Sparks; Timothy Schacker; Bradley Benson; Jeffrey A. Sparks; Thomas Murray; John Connett; Jeffrey G. Chipman; Anthony Charles; Christopher J. Tignanelli

doi:10.1186/s13054-020-02894-7

Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2

Nicholas E. Ingraham, David Boulware, Matthew A. Sparks, Timothy Schacker, Bradley Benson, Jeffrey A. Sparks, Thomas Murray, John Connett, Jeffrey G. Chipman, Anthony Charles, Christopher J. Tignanelli

Research output: Contribution to journal › Comment/debate › peer-review

9 Scopus citations

Original language	English (US)
Article number	182
Journal	Critical Care
Volume	24
Issue number	1
DOIs	https://doi.org/10.1186/s13054-020-02894-7
State	Published - Apr 28 2020

Bibliographical note

Funding Information:
Nicholas E. Ingraham is supported by the NIH NHLBI T32HL07741 grant.

Funding Information:
3. JAS: Site PI of a phase 2 RCT investigating HCQ for the prevention of rheumatoid arthritis (funded by NIH/NIAID/Autoimmune Centers of Excellence) and has performed consultancy for Bristol-Myers Squibb, Gilead, Inova, Janssen, and Optum unrelated to this work.

Keywords

COVID-19
Evidence-based medicine
Hydroxychloroquine
Pandemic
RCT
SARS

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1186/s13054-020-02894-7

OpenUrl availability

Full text

Cite this

@article{d9e3f18191204c6c90e23c358a589f4a,

title = "Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2",

keywords = "COVID-19, Evidence-based medicine, Hydroxychloroquine, Pandemic, RCT, SARS",

author = "Ingraham, {Nicholas E.} and David Boulware and Sparks, {Matthew A.} and Timothy Schacker and Bradley Benson and Sparks, {Jeffrey A.} and Thomas Murray and John Connett and Chipman, {Jeffrey G.} and Anthony Charles and Tignanelli, {Christopher J.}",

note = "Funding Information: Nicholas E. Ingraham is supported by the NIH NHLBI T32HL07741 grant. Funding Information: 3. JAS: Site PI of a phase 2 RCT investigating HCQ for the prevention of rheumatoid arthritis (funded by NIH/NIAID/Autoimmune Centers of Excellence) and has performed consultancy for Bristol-Myers Squibb, Gilead, Inova, Janssen, and Optum unrelated to this work.",

year = "2020",

month = apr,

day = "28",

doi = "10.1186/s13054-020-02894-7",

language = "English (US)",

volume = "24",

journal = "Critical Care",

issn = "1364-8535",

publisher = "BioMed Central Ltd.",

number = "1",

}

TY - JOUR

T1 - Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2

AU - Ingraham, Nicholas E.

AU - Boulware, David

AU - Sparks, Matthew A.

AU - Schacker, Timothy

AU - Benson, Bradley

AU - Sparks, Jeffrey A.

AU - Murray, Thomas

AU - Connett, John

AU - Chipman, Jeffrey G.

AU - Charles, Anthony

AU - Tignanelli, Christopher J.

N1 - Funding Information: Nicholas E. Ingraham is supported by the NIH NHLBI T32HL07741 grant. Funding Information: 3. JAS: Site PI of a phase 2 RCT investigating HCQ for the prevention of rheumatoid arthritis (funded by NIH/NIAID/Autoimmune Centers of Excellence) and has performed consultancy for Bristol-Myers Squibb, Gilead, Inova, Janssen, and Optum unrelated to this work.

PY - 2020/4/28

Y1 - 2020/4/28

KW - COVID-19

KW - Evidence-based medicine

KW - Hydroxychloroquine

KW - Pandemic

KW - RCT

KW - SARS

UR - http://www.scopus.com/inward/record.url?scp=85084107001&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85084107001&partnerID=8YFLogxK

U2 - 10.1186/s13054-020-02894-7

DO - 10.1186/s13054-020-02894-7

M3 - Comment/debate

C2 - 32345336

AN - SCOPUS:85084107001

SN - 1364-8535

VL - 24

JO - Critical Care

JF - Critical Care

IS - 1

M1 - 182

ER -

Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2

Bibliographical note

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Cite this